Kiniksa Pharmaceuticals
KNSA
KNSA
188 hedge funds and large institutions have $1.1B invested in Kiniksa Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 48 funds opening new positions, 65 increasing their positions, 62 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
5% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 62
1.08% less ownership
Funds ownership: 95.15% → 94.07% (-1.1%)
77% less call options, than puts
Call options by funds: $8.22M | Put options by funds: $36.2M
Holders
188
Holding in Top 10
3
Calls
$8.22M
Puts
$36.2M
Top Buyers
| 1 | +$20.3M | |
| 2 | +$18.6M | |
| 3 | +$18.1M | |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$14.6M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$12.4M |
Top Sellers
| 1 | -$75.5M | |
| 2 | -$23.8M | |
| 3 | -$17.6M | |
| 4 |
NL
Nuveen LLC
Charlotte,
North Carolina
|
-$17M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$12.6M |
